MTHFD1 and lung adenocarcinoma: A current study found that MTHFD1 levels were not only associated with prognosis after CRT treatment of small cell lung cancer patients, but could also discriminate SCLC from both lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) [56].